Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/SRT3 stock hub

ETR/SRT3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/SRT3is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
13.5B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/SRT3
In the news

Latest news · ETR/SRT3

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E54.9
P25 12.3P50 15.7P75 20.2
Trailing P/E82.9
P25 16.4P50 20.9P75 30.4
ROE6.2
P25 -6.7P50 8.5P75 17.2
ROIC5.3
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/SRT3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
EUR
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
DE
Employees
14,242
Employees Change
669%
Employees Change Percent
4.93
Enterprise value
EUR 18.4B
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
DE0007165631
Last refreshed
2026-05-10
Market cap
EUR 13.5B
Price
EUR 217
Price currency
EUR
Rev Per Employee
249,557.65x
Sector
Healthcare
Sic
3826
Symbol
etr/SRT3
Website
https://www.sartorius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
1.21%
EV Earnings
113.02x
EV/EBIT
31.65x
EV/EBITDA
19.53x
EV/FCF
41.46x
EV/Sales
5.17x
FCF yield
3.29%
Forward P/E
54.93x
P/B ratio
3.47x
P/E ratio
82.94x
P/S ratio
3.79x
PE Ratio10 Y
85x
PE Ratio3 Y
118.43x
PE Ratio5 Y
98.24x
PEG ratio
2.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
16.43%
EBITDA Margin
25.48%
FCF margin
12.47%
Gross margin
45.59%
Gross Profit
EUR 1.6B
Gross Profit Growth
3.93%
Gross Profit Growth Q
-3.83%
Gross Profit Growth3 Y
-8.47%
Gross Profit Growth5 Y
3.57%
Net Income
EUR 162.6M
Net Income Growth
70.08%
Net Income Growth Q
15.88%
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Net Income Growth3 Y
-34%
Net Income Growth5 Y
-8.55%
Pretax Margin
9.8%
Profit Margin
4.57%
Profit Per Employee
EUR 11,417
Profitable Years
24
ROA
3.65
Roa5y
6.71
ROCE
7.53
ROE
6.18
Roe5y
18.01
ROIC
5.26
Roic5y
11.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
15.33%
Cagr15y
24.36%
Cagr1y
-3.57%
Cagr20y
19.61%
Cagr3y
-15.55%
Cagr5y
-13.24%
Div CAGR10
6.89%
Div CAGR3
0%
Div CAGR5
-10.1%
EPS Growth Quarters
5
EPS Growth Years
1
FCF Growth
-37.78%
FCF Growth Q
76.23%
FCF Growth3 Y
34.56%
FCF Growth5 Y
4.82%
OCF Growth
-17.13%
OCF Growth Q
35.7%
OCF Growth10 Y
20.97%
OCF Growth3 Y
6.04%
OCF Growth5 Y
7.19%
Revenue Growth
3.2x
Revenue Growth Q
1.82x
Revenue Growth Quarters
6x
Revenue Growth Years
1x
Revenue Growth3 Y
-4.28x
Revenue Growth5 Y
6.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.36
Assets
EUR 9.9B
Cash
EUR 573.8M
Current Assets
EUR 1.9B
Current Liabilities
EUR 2.1B
Debt
EUR 4.3B
Debt EBITDA
EUR 4.56
Debt Equity
EUR 1.11
Debt FCF
EUR 9.7
Equity
EUR 3.9B
Interest Coverage
3.58
Liabilities
EUR 6B
Long Term Assets
EUR 7.9B
Long Term Liabilities
EUR 3.9B
Net Cash
EUR -3.7B
Net Cash By Market Cap
EUR -27.64
Net Debt EBITDA
EUR 4.12
Net Debt Equity
EUR 0.96
Net Debt FCF
EUR 8.41
Tangible Book Value
EUR -2.6B
WACC
9.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.91
Inventory Turnover
2.39
Net Working Capital
EUR 200.2M
Quick ratio
0.45
Working Capital
EUR -189.8M
Working Capital Turnover
EUR 14.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
EUR 0.74
Dividend Years
33
Dividend Yield
0.34%
Ex Div Date
2026-03-27
Last Dividend
EUR 0.74
Payout Frequency
Annual
Payout Ratio
62.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
316.33%
1Y total return
-3.57%
200-day SMA
223.1
3Y total return
-39.77%
50-day SMA
220.3
50-day SMA vs 200-day SMA
50under200
5Y total return
-50.83%
All Time High
631.6
All Time High Change
-65.66%
All Time High Date
2021-11-30
All Time Low
0.81
All Time Low Change
26,595.38%
All Time Low Date
2002-10-14
ATR
9.82
Beta
1.4
Beta1y
1.45
Beta2y
1.39
Ch YTD
-12.26
High
221
High52
267.7
High52 Date
2026-01-08
High52ch
-18.98%
Low
214.8
Low52
176
Low52 Date
2025-08-07
Low52ch
23.27%
Ma50ch
-1.55%
Price vs 200-day SMA
-2.77%
RSI
46.84
RSI Monthly
44.07
RSI Weekly
46.33
Sharpe ratio
-0.06x
Sortino ratio
0.07
Total Return
0.34%
Tr YTD
-11.95
Tr15y
2,532.87%
Tr1m
4.23%
Tr1w
0.09%
Tr3m
-9.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 583.9M
Operating Income Growth
24.55
Operating Income Growth Q
11.85
Operating Income Growth3 Y
-18.41
Operating Income Growth5 Y
-0.99
Operating margin
16.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
27,448,420%
Net Borrowing
-332,600,000
Shares Institutions
15.06%
Shares Out
69,038,196

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
EUR 443.2M
Average Volume
100,315.8x
CAPEX
EUR -443.5M
Ch10y
303
Ch15y
2,310
Ch1m
4.23
Ch1w
0.09
Ch1y
-3.9
Ch20y
2,753.9
Ch3m
-9.47
Ch3y
-40.3
Ch5y
-51.6
Ch6m
-2.3
Change
-2.08%
Change From Open
-1.36
Close
221.5
Days Gap
-0.72
Depreciation Amortization
321,600,000
Dollar Volume
13,100,976.9
Earnings Date
2026-04-23
EBIT
EUR 583.9M
EBITDA
EUR 905.5M
F Score
7
FCF
EUR 443.2M
FCF EV Yield
2.41x
FCF Per Share
EUR 6.42
Financing CF
-637,900,000
Fiscal Year End
December
Founded
1,870
Goodwill
3,485,000,000
Graham Number
60.68245
Graham Upside
-72.02
Income Tax
EUR 109.6M
Investing CF
-511,800,000
Is Primary Listing
1
Last Earnings Date
2026-04-23
Last Report Date
2026-03-31
Last Split Date
2016-06-13
Last Split Type
Forward
Lynch Fair Value
EUR 13.08
Lynch Upside
-93.97
Ma150
232.6
Ma150ch
-6.76%
Ma20
223.4
Ma20ch
-2.91%
Net CF
-265,700,000
Next Earnings Date
2026-07-23
Open
219.9
P FCF Ratio
30.43
P OCF Ratio
15.21
Payment Date
2026-03-31
Position In Range
33.87
Ppne
2,462,500,000
Price Date
2026-05-08
Price EBITDA
EUR 14.89
Relative Volume
0.62x
Revenue
3,554,200,000x
Tax By Revenue
3.08x
Tax Rate
31.47%
Tr20y
3,494.08%
Tr6m
-1.96%
Volume
60,401
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ETR/SRT3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.3%
$0.74 annual per share
Payout ratio
+62.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-10.1%
0 consecutive years of growth
Total shareholder yield
+0.3%
Next ex-dividend date: 2026-03-27
Performance

ETR/SRT3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-3.6%
S&P 500 1Y: n/a
3Y total return
-39.8%
S&P 500 3Y: n/a
5Y total return
-50.8%
S&P 500 5Y: n/a
10Y total return
+316.3%
S&P 500 10Y: n/a
Ownership

Who owns ETR/SRT3?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.1%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

ETR/SRT3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.8
Neutral momentum band
Price vs 200-day MA
-2.8%
50/200-day relationship not available
Beta (5Y)
1.40
More volatile than the market
Sharpe ratio
-0.06
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/SRT3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/SRT3 stock rating?

etr/SRT3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/SRT3 analysis?

The full report lives at /stocks/etr/SRT3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/SRT3?

The latest report frames etr/SRT3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/SRT3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.